American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Interactive Brokers
IBKR
|
+$222M |
| 2 |
Martin Marietta Materials
MLM
|
+$168M |
| 3 |
Fiserv
FI
|
+$123M |
| 4 |
VICI Properties
VICI
|
+$121M |
| 5 |
Reinsurance Group of America
RGA
|
+$120M |
Top Sells
| 1 |
Apple
AAPL
|
+$522M |
| 2 |
NVIDIA
NVDA
|
+$496M |
| 3 |
Microsoft
MSFT
|
+$317M |
| 4 |
Eli Lilly
LLY
|
+$273M |
| 5 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$231M |
Sector Composition
| 1 | Technology | 24.77% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Healthcare | 10.87% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THRD
2751
DELISTED
Third Harmonic Bio
THRD
| $110K | ﹤0.01% |
31,667
+4,417
| +16% | +$15.3K |
|
|
USAS
2752
Americas Gold and Silver
USAS
$788M
| $108K | ﹤0.01% |
80,806
+6,206
| +8% | +$8.3K |
|
2753
Sensus Healthcare
SRTS
$52.4M
| $106K | ﹤0.01% |
22,440
+2,520
| +13% | +$11.9K |
|
2754
Melco Resorts & Entertainment
MLCO
$3.79B
| $106K | ﹤0.01% |
20,025
| – | – |
|
2755
ProQR Therapeutics
PRQR
$215M
| $103K | ﹤0.01% |
77,686
-11,841
| -13% | -$15.7K |
|
2756
Vivid Seats
SEAT
$114M
| $102K | ﹤0.01% |
1,722
-3,098
| -64% | -$183K |
|
2757
CommScope
COMM
$3.68B
| $90.9K | ﹤0.01% |
+17,115
| New | +$90.9K |
|
2758
Traeger
COOK
$174M
| $90.2K | ﹤0.01% |
53,662
-288
| -0.5% | -$484 |
|
2759
Tango Therapeutics
TNGX
$737M
| $89.3K | ﹤0.01% |
65,146
-45,302
| -41% | -$62.1K |
|
|
TE
2760
T1 Energy Inc.
TE
$282M
| $88.8K | ﹤0.01% |
+70,510
| New | +$88.8K |
|
|
TUYA
2761
Tuya Inc
TUYA
$1.58B
| $88.7K | ﹤0.01% |
29,270
+58
| +0.2% | +$176 |
|
|
SBDS
2762
Solo Brands, Inc.
SBDS
$26.8M
| $86K | ﹤0.01% |
512,535
-5,029,447
| -91% | -$844K |
|
2763
Altimmune
ALT
$316M
| $85.9K | ﹤0.01% |
17,175
-27,567
| -62% | -$138K |
|
2764
Aehr Test Systems
AEHR
$814M
| $85.7K | ﹤0.01% |
+11,752
| New | +$85.7K |
|
2765
inTEST
INTT
$90.6M
| $85.1K | ﹤0.01% |
12,180
-29
| -0.2% | -$203 |
|
2766
Iovance Biotherapeutics
IOVA
$825M
| $83.2K | ﹤0.01% |
24,974
-101,680
| -80% | -$339K |
|
2767
Zegna
ZGN
$2.29B
| $80.2K | ﹤0.01% |
10,840
| – | – |
|
2768
Inotiv
NOTV
$48.4M
| $79.6K | ﹤0.01% |
36,039
-3,446
| -9% | -$7.62K |
|
2769
Richtech Robotics
RR
$599M
| $78.3K | ﹤0.01% |
+39,524
| New | +$78.3K |
|
2770
Zynex
ZYXI
$43.9M
| $78K | ﹤0.01% |
35,451
-245
| -0.7% | -$539 |
|
2771
VistaGen Therapeutics
VTGN
$101M
| $77.7K | ﹤0.01% |
31,063
+1,061
| +4% | +$2.65K |
|
2772
Adverum Biotechnologies
ADVM
$65.1M
| $77.1K | ﹤0.01% |
17,647
+1,370
| +8% | +$5.99K |
|
2773
Zentalis Pharmaceuticals
ZNTL
$104M
| $74.6K | ﹤0.01% |
46,900
+14,816
| +46% | +$23.6K |
|
2774
Ultralife
ULBI
$115M
| $74K | ﹤0.01% |
13,747
-310
| -2% | -$1.67K |
|
2775
ESSA Pharma
EPIX
$9.12M
| $73.3K | ﹤0.01% |
46,373
| – | – |
|